Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/123456789/4404
Full metadata record
DC FieldValueLanguage
dc.creatorPandey M-
dc.creatorThomas S-
dc.creatorMathew A-
dc.creatorNair M-
dc.date2003-
dc.date.accessioned2013-05-30T11:10:13Z-
dc.date.available2013-05-30T11:10:13Z-
dc.date.issued2013-05-30-
dc.identifierhttp://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=1;spage=25;epage=8;aulast=Pandey-
dc.identifierhttp://www.doaj.org/doaj?func=openurl&genre=article&issn=00223859&date=2003&volume=49&issue=1&spage=25-
dc.identifier.urihttp://koha.mediu.edu.my:8181/jspui/handle/123456789/4404-
dc.descriptionBACKGROUND: Malignant tumours of the minor salivary glands are rare and constitute less than 0.5% of all malignant neoplasms. AIM: This study was carried out to evaluate the clinical presentation, site distribution, treatment, survival and predictors of survival in malignant minor salivary gland tumours. SETTING: A tertiary care, superspeciality referral hospital. DESIGN: Retrospective analysis. PATIENTS AND METHOD: Forty-two cases of minor salivary gland tumours treated over a period of 17 years were reviewed for clinical presentation, histopathology, stage distribution, treatment and treatment outcome. STATISTICAL ANALYSIS: Survival by Kaplan Meier Method and the outcomes were compared using log-rank test. RESULTS: The mean age of the patients was 46.9 years with a male to female ratio of 1.4:1. Majority of the patients presented with a painless progressive swelling, with 13 (31%) of them in T2 stage. About one-third of the patients had palpable lymph nodes at presentation, while none had distant metastasis. Palate was the commonest site and mucoepidermoid carcinoma was the commonest hispathological type. About 1/3 of the patients were treated with primary surgery and were followed up by adjuvant radiotherapy. Seven patients underwent palliative treatment alone. Over a mean follow-up of 30 months, 5 patients failed. The disease free survival was 72% at 5-year, none of the factors studied were found to significantly influence survival. CONCLUSIONS: Results of the present study suggest that minor salivary gland tumours should be treated with primary surgery irrespective of site and histological type to achieve best loco-regional control and survival.-
dc.publisherMedknow Publications-
dc.sourceJournal of Postgraduate Medicine-
dc.subjectAdolescent-
dc.subjectAdult-
dc.subjectAged-
dc.subjectCarcinoma-
dc.subjectdiagnosis-
dc.subjectpathology-
dc.subjecttherapy-
dc.subjectDisease-Free Survival-
dc.subjectFemale-
dc.subjectHuman-
dc.subjectMale-
dc.subjectMiddle Age-
dc.subjectNeoplasm Staging-
dc.subjectPalate-
dc.subjectpathology-
dc.subjectRetrospective Studies-
dc.subjectSalivary Gland Neoplasms-
dc.subjectdiagnosis-
dc.subjectpathology-
dc.subjecttherapy-
dc.subjectSurvival Analysis-
dc.subjectTreatment Outcome-
dc.titleMalignant tumours of the minor salivary glands: a survival analysis of 17 years from a tertiary referral cancer centre.-
Appears in Collections:Health Sciences

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.